Presentation Information
[Pe-054-1]Methotrexate as the second line therapy for neurosarcoidosis
Hiroshi Kuroda1,2,3, Yoshiki Takai3, Kimihiko Kaneko3, Yuki Matsumoto3, Chihiro Namatame3, Toshiyuki Takahashi3, Tatsuro Misu3, Kazuo Fujihara1,2, Masashi Aoki3 (1.Department of Neurology, Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU General Hospital, Japan, 2.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan, 3.Department of Neurology, Tohoku University Graduate School of Medicine, Japan)